Data / Form D filings / Olive Medical Corp
Olive Medical Corp: Form D filings
Olive Medical Corp, a biotechnology company in Sandy, UT, filed 4 Form D notices with the SEC between 2009 and 2011. The latest, on November 28, 2011, reports $1 million sold of an offering with no set size to 17 investors.
Find out what Olive Medical Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9690 SOUTH 300 WEST, SUITE 320 H, Sandy, UT, 84070
- Phone
- (972) 740-2366
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Utah
- Year incorporated
- 2009
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1476058
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 28, 2011 | New notice | Indefinite | $1,000,000 | Indefinite | 17 | Oct 18, 2011 | sec.gov |
| Dec 10, 2010 | Amendment | $1,324,000 | $871,500 | $452,500 | 20 | Nov 5, 2010 | sec.gov |
| Nov 17, 2010 | New notice | $1,324,000 | $488,500 | $835,500 | 13 | Nov 5, 2010 | sec.gov |
| Nov 4, 2009 | New notice | $500,000 | $200,000 | $300,000 | 9 | Oct 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| S. George Simon | Director | |
| J. Michael Brown | Director | |
| Curtis Wichern | Executive Officer | |
| Laurant George Blanquart | Executive Officer | |
| Jeremiah Henley | Executive Officer | |
| Dann George Hughes | Director | |
| Joshua Talbert | Executive Officer, Director | |
| Donald Wichern | Executive Officer, Director |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 14 LLC offering · Nov 9, 2026
- Life Impact Partners 15 LLC offering · Nov 9, 2026
- Life Impact Partners 7 LLC offering · Nov 6, 2026
- Life Impact Partners 6 LLC offering · Nov 6, 2026
- Life Impact Partners 3 LLC offering · Nov 6, 2026
- Life Impact Partners 5 LLC offering · Nov 6, 2026
- Life Impact Partners 4 LLC offering · Nov 6, 2026
- Life Impact Partners 2 LLC offering · Nov 6, 2026
- Life Impact Partners 8 LLC offering · Nov 6, 2026
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of Nov 28, 2011 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Olive Medical Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.